Zobrazeno 71 - 80
of 296
pro vyhledávání: '"Matthias Girndt"'
Background: An association between hypoglycemia and arterial hypertension is unknown. Here, we report a case of a chronically over-dosed insulin therapy in conjunction with uncontrolled hypertension.Case Presentation: A 73-year-old, male diabetic of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97664858fda8d72ae28d820394b9e27a
https://doi.org/10.21203/rs.3.rs-76963/v1
https://doi.org/10.21203/rs.3.rs-76963/v1
Publikováno v:
Diabetes Therapy
Introduction Real-world data indicate that sodium glucose transporter-2–inhibitor therapy and/or incretin mimetics are not widely prescribed in type-2 diabetics with atherosclerotic vascular disease. We hypothesized that incretin-mimetic therapy is
Background: We hypothesized that the recommended incretin-mimetic therapy associates with a better outcome (1-year mortality after discharge, rehospitalizations within 12 months) and with less hypoglycemic events in type − 2 diabetics following myo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::682e71ebe4a4890265a4b9032dc5440d
https://doi.org/10.21203/rs.3.rs-52203/v1
https://doi.org/10.21203/rs.3.rs-52203/v1
Autor:
Susann Wildgrube, Leonie Kneser, Julia Beckert, Christof Ulrich, Roman Fiedler, Christoph Schäfer, Bogusz Trojanowicz, Sylvia Fick, Eric Seibert, Silke Markau, Matthias Girndt
Publikováno v:
Toxins; Volume 13; Issue 12; Pages: 839
Toxins
Toxins, Vol 13, Iss 839, p 839 (2021)
Toxins
Toxins, Vol 13, Iss 839, p 839 (2021)
NLRP-3 inflammasome activation can result in interleukin-1β (IL-1β) release and inflammatory cell death (pyroptosis). Caspase-1 is able to trigger both processes. However, other caspases, caspase-4, -5 and -8, are believed to initiate pyroptosis wi
Autor:
Martin Bommer, Silke Markau, Wolfram J. Jabs, Charis von Auer, Markus Bieringer, Paul T. Brinkkoetter, Martin Reinhardt, Regina Herbst, Sebastian Brähler, Anja Mühlfeld, Jörg Radermacher, Frederic Bauer, Ralph Wendt, Johanna Schneider, Jan Menne, Hildegard Christ, Alexander Gawlik, Lucas Kühne, Timm H. Westhoff, Saban Elitok, Wolfgang Miesbach, Anja Gäckler, Sebastian A. Potthoff, Jens Gerth, Helmut Felten, M. Tölle, Fedai Özcan, Maximilian Roeder, Jörn Bramstedt, Jessica Kaufeld, Andreas Kribben, Martin Hausberg, Anke Morgner, Jens Gaedeke, Linus A. Völker, Marcus Brand, Stefan Zschiedrich, Adrian Schreiber, Ulf Schoenermarck, Vedat Schwenger, Ana Harth, Matthias Girndt
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare but life-threatening condition. In 2018, the nanobody caplacizumab was approved for the treatment of adults experiencing an acute episode of aTTP, in conjunction with plasma exchange (PEX)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3da1d0e9664bad0a2333cb332710f7d7
http://edoc.mdc-berlin.de/19118/1/19118oa.pdf
http://edoc.mdc-berlin.de/19118/1/19118oa.pdf
Autor:
M. Tölle, Wolfram J. Jabs, Fedai Özcan, Lucas Kühne, Jan Menne, Regina Herbst, Timm H. Westhoff, Paul T. Brinkkoetter, Sebastian A. Potthoff, Andreas Kribben, Vedat Schwenger, Alexander Gawlik, Martin Reinhardt, Silke Markau, Ralph Wendt, Anke Morgner, Anja Mühlfeld, Ana Harth, Saban Elitok, Wolfgang Miesbach, Jörg Radermacher, Johanna Schneider, Martin Hausberg, Charis von Auer, Martin Bommer, Markus Bieringer, Maximilian Roeder, Jörn Bramstedt, Frederic Bauer, Helmut Felten, Ulf Schoenermarck, Matthias Girndt, Hildegard Christ, Jessica Kaufeld, Anja Gäckler, Jens Gerth, Jens Gaedeke, Sebastian Brähler, Adrian Schreiber, Linus A. Völker, Marcus Brand, Stefan Zschiedrich
Publikováno v:
Blood Adv
Introduction of the nanobody caplacizumab was shown to be effective in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in the acute setting. The official recommendations include plasma exchange (PEX), immunosuppression, and the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::925b2ff5793d83294a1ac70f7d152044
http://edoc.mdc-berlin.de/19119/1/19119oa.pdf
http://edoc.mdc-berlin.de/19119/1/19119oa.pdf
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Hypervolemia is frequent in haemodialysis (HD) patients and is linked to inflammation, which may be further enhanced by endotoxemia. The impact of hypervolemia on immune cells i.e. a main monocytic defence mechanism - the NLRP3 in
Autor:
Babett Bartling, Alexander Tamm, Matthias Girndt, Rainer U Pliquett, Andreas Wienke, Michel Noutsias, Katrin Schlump
Background Cardiorenal syndrome (CRS) defined as concurrent acute or chronic heart failure and acute or chronic kidney injury or disease frequently coincides with hyponatremia. We sought to identify potential risk factors for and outcome of hyponatre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dcbe44f478ffbd043eddf858a1711f0
https://doi.org/10.21203/rs.3.rs-17244/v1
https://doi.org/10.21203/rs.3.rs-17244/v1
Publikováno v:
Toxins, Vol 12, Iss 3, p 159 (2020)
Toxins
Volume 12
Issue 3
Toxins
Volume 12
Issue 3
Dysregulated fluid homeostasis is frequent in haemodialysis (HD) patients and is linked to inflammation which may be elicited by endotoxemia. The impact of hypervolemia on immune cells has not been studied in detail. Therefore, we analysed the hyperv
Publikováno v:
Journal of Medical Case Reports
Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-5 (2020)
Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-5 (2020)
Background Treatment of active rheumatoid arthritis may necessitate a methotrexate mono- or combination therapy. As in the present case, novel side effects may occur, when escalating therapy. Case presentation A 63-year-old Caucasian female patient w